RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee | MicrobiomeTrials← Back to trialsNCT05318521
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2021-12-10Est. Completion: 2022-08-12
Enrollment target: 500 participants Locations- Core Healthcare, Cerritos, California, United States
- National Institute of Clinical Research, Garden Grove, California, United States
- Paragon Rx Clinical, Inc., Santa Ana, California, United States
- Well Pharma Medical Research, Miami, Florida, United States
- Palm Beach Research Center, West Palm Beach, Florida, United States
- Coastal Carolina Research Center, North Charleston, South Carolina, United States
- Cvillemedresearch, Charlottesville, Virginia, United States
- Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan
- China Medical University Hospital, Taichung, Taiwan
- Taipei Medical University Hospital, Taipei, Taiwan
- Taipei Municipal Wanfang Hospital, Taipei, Taiwan
Other microbiome trials you might be interested in
Knee Osteoarthritis
The study aims to evaluate the therapeutic effect of the Tui-na and oral Chinese medicine on the treatment of KOA.
This…
Hong Kong, Hong KongCompleted Oct 31, 2021
Knee OsteoarthritisSynovitis of Knee
This phase 2a trial is an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate …
Tucson, United StatesEst. completion Aug 28, 2026